SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,560.00    110.00 (2.47%)
Bid:
4,530.00
Ask:
4,590.00
Spread: 60.00 (1.325%)
Market Cap: £303.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
9th May 20247:00 amRNSPurchase of Ordinary Shares
8th May 20241:21 pmRNSDirector/PDMR Shareholding
3rd May 20243:01 pmRNSNotice of General Meeting
1st May 20247:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSDirector/PDMR Shareholding
9th Apr 20245:29 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:41 amRNSTotal Voting Rights - Correction
2nd Apr 20249:03 amRNSTotal Voting Rights
25th Mar 20246:01 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
4th Mar 202411:04 amRNSTotal Voting Rights
22nd Feb 20245:20 pmRNSHolding(s) in Company
6th Feb 20243:03 pmRNSDirector/PDMR Shareholding
5th Feb 20249:32 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSAcquisition of Luciol Instruments SA
24th Jan 20245:52 pmRNSGrant of Options
18th Jan 20247:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 20242:21 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:49 amRNSTotal Voting Rights
21st Dec 20234:16 pmRNSDirector/PDMR Shareholding
21st Dec 20239:13 amRNSBlock listing Interim Review
7th Dec 202311:18 amRNSDirector/PDMR Shareholding
1st Dec 202311:20 amRNSTotal Voting Rights
22nd Nov 202310:41 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSBoard Changes
15th Nov 202312:54 pmRNSDirector/PDMR Shareholding
9th Nov 202312:36 pmRNSDirector/PDMR Shareholding
9th Oct 202311:36 amRNSDirector/PDMR Shareholding
3rd Oct 202311:13 amRNSTotal Voting Rights
26th Sep 202310:37 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Investor Presentation
2nd Aug 20233:02 pmRNSTotal Voting Rights
26th Jul 202311:20 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
10th Jul 20233:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:44 pmRNSTotal Voting Rights
22nd Jun 20233:09 pmRNSBlock listing Interim Review
14th Jun 20238:44 amRNSDirector/PDMR Shareholding
6th Jun 20238:45 amRNSPayment of Earn-out and Issue of Equity
5th Jun 20234:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSBlocklisting Application and Total Voting Rights
22nd May 20231:45 pmRNSResult of AGM
12th May 20232:01 pmRNSPurchase of Ordinary Shares
9th May 202312:37 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSNotice of AGM
2nd May 20231:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSAcquisition of Bossa Nova Vision LLC
25th Apr 20235:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.